Cambria Investment Management, L.P. United Therapeutics Corp Transaction History
Cambria Investment Management, L.P.
- $1.56 Billion
- Q4 2024
A detailed history of Cambria Investment Management, L.P. transactions in United Therapeutics Corp stock. As of the latest transaction made, Cambria Investment Management, L.P. holds 1,074 shares of UTHR stock, worth $312,942. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,074
Previous 1,192
9.9%
Holding current value
$312,942
Previous $427,000
11.48%
% of portfolio
0.02%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding UTHR
# of Institutions
728Shares Held
40.8MCall Options Held
123KPut Options Held
104K-
Black Rock Inc. New York, NY5.47MShares$1.59 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.29 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$804 Million14.19% of portfolio
-
State Street Corp Boston, MA2.2MShares$641 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.09MShares$609 Million1.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $13.3B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...